Abbott India
BSE: 500488 | NSE: ABBOTINDIA | ISIN: INE358A01014 | SECTOR: Biotechnology & DrugsOpen
26,263.00High
26,263.00Low
25,666.65Prev Close
26,261.45P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
548.93BVolume
0.62KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
25,744.30
Company Description
- Biotechnology & Drugs
BSE
500488NSE
ABBOTINDIAISIN
INE358A01014
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
Company Officers
Sridhar Kadangode
Chief Financial OfficerSangeeta Shetty
Chief Compliance Officer, Company SecretarySwati Dalal
Managing Director, Additional DirectorKunal Chowdhury
Commercial Director - GI BusinessRajan Kalantre
Director - Business Human ResourcesJejoe Karankumar
Director - Medical AffairsMurari Ranganathan
Commercial Director - Womens Health, Metabolics and International BusinessSandeep Reddy
Commercial Director - Women's Health, Metabolics & International BusinessAshok Saini
Commercial Director - GenNext, Vaccine and NeurolifeNamita Shah
Associate Director - New Product Introductions and Therapy Area Strategy